Chabannon, Christian <br/><br/>
Considerations pertaining to cell collection and administration of industry-manufactured autologous CAR-T cells, in relation to French healthcare organization and regulations.  [electronic resource] 

 -  Current research in translational medicine  05 2018 
 - 59-61 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>2452-3186 
<br/><br/><label>Standard No.: </label>10.1016/j.retram.2018.03.002  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Cell Separation--methods<br/>Cell- and Tissue-Based Therapy--methods<br/>Clinical Trials as Topic--legislation & jurisprudence<br/>Commerce<br/>Delivery of Health Care--legislation & jurisprudence<br/>France<br/>Humans<br/>Immunotherapy, Adoptive--legislation & jurisprudence<br/>Legislation, Medical<br/>Receptors, Chimeric Antigen--therapeutic use<br/>T-Lymphocytes--transplantation<br/>Tissue and Organ Harvesting--legislation & jurisprudence